What is ATL1102 capable of?
Another possibility that conduct by a team of Australian researchers and clinicians from UNSW Sydney's Kirby Institute and St Vincent's Hospital Sydney have uncovered an immune profile for long Covid, potentially paving the way for tailored treatment for those with ongoing symptoms:
"... biological characteristics which can help us define a medical condition in an accurate and reproducible way. We compared these to people who had not had Covid-19, and we found persistently elevated level of Type I and Type III interferons - types of protein that cells make in response to the presence of a virus. These interferons generally disappear after an infection clears, but in patients with long Covid we found hey were present for an extended period."... " In conducting this research, we were looking for proteins in the serum, these proteins, or biomarkers, are evidence of an abnormal process caused by a disease. We analysed 29 different biomarkers that we suspected could be 'triggered' by Covid 19, and we identified a small subset that were associated with long Covid syndrome. Excitingly, by looking at subsets of cells within the immune system we found the possible of those biomarkers, which could be crucial for developing treatments."
Now, let's see Antisense... Antisense drugs prevent the production of proteins in disease processes by interrupting the translation phase of the protein production which results in therapeutics benefit to patients.
As Wilsons Equity Research pointed out, " If Antisense were to pursue indication expansion of ATL1102 outside of DMD, MS is their most advanced asset and opportunity given the advanced clinical development they have already completed."
Let's see what the future holds... 1) By hook or by crook, we will get sufficient funds for the trial on time, I'm not worried at all. 2) the pivotal trial (DMD) in EU commenced. 3) once the nine-month toxicology study finished and hopefully by then FDA lifted the partial clinical hold... get the ball rolling...
I believe the company has done a lot of work behind the scenes and we will continue to make progress. Sometime I don't have to have all things figured out to look forward.. just follow company timeline. A small biotech company like ANP with no revenue can still be worth billion of dollars... Pipeline often justify the value of a company. It will not happen overnight... It's a long game....
